Collectively, our study demonstrates the novel mechanism of PIN1/CDK1 to cooperatively destabilize pVHL and promote tumor progression, thereby targeting PIN1 and CDK1 might be potential therapeutic strategies in the treatment of TNBC and other cancers with wild-type VHL (Fig. 7N). Here, VHL is linked to neoplasm.